Sharon Anderson

2.1k total citations
36 papers, 1.6k citations indexed

About

Sharon Anderson is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sharon Anderson has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sharon Anderson's work include Chronic Kidney Disease and Diabetes (13 papers), Blood Pressure and Hypertension Studies (5 papers) and Dialysis and Renal Disease Management (4 papers). Sharon Anderson is often cited by papers focused on Chronic Kidney Disease and Diabetes (13 papers), Blood Pressure and Hypertension Studies (5 papers) and Dialysis and Renal Disease Management (4 papers). Sharon Anderson collaborates with scholars based in United States, Switzerland and Czechia. Sharon Anderson's co-authors include Florian Jung, Julie R. Ingelfinger, T Oyama, Radko Komers, Barry M. Brenner, B M Brenner, Richard J. Johnson, Katherine Gordon, Stuart J. Shankland and Susan E. Thomas and has published in prestigious journals such as Diabetes, Pain and Kidney International.

In The Last Decade

Sharon Anderson

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Anderson United States 21 662 519 377 362 183 36 1.6k
Eberhard Ritz Germany 12 864 1.3× 502 1.0× 513 1.4× 317 0.9× 131 0.7× 12 1.8k
A S Krolewski United States 20 603 0.9× 451 0.9× 775 2.1× 297 0.8× 234 1.3× 29 1.8k
Masahito Imanishi Japan 24 328 0.5× 487 0.9× 287 0.8× 258 0.7× 212 1.2× 73 1.4k
Mari-Anne Gall Denmark 17 667 1.0× 725 1.4× 797 2.1× 253 0.7× 174 1.0× 26 2.1k
Gerjan Navis Netherlands 22 480 0.7× 311 0.6× 270 0.7× 275 0.8× 140 0.8× 60 1.4k
Tatsuo Shiigai Japan 25 711 1.1× 433 0.8× 313 0.8× 359 1.0× 206 1.1× 106 2.1k
Sandra Donnelly Canada 23 798 1.2× 337 0.6× 374 1.0× 268 0.7× 181 1.0× 51 2.0k
Antonio Bossi Italy 17 665 1.0× 647 1.2× 731 1.9× 307 0.8× 224 1.2× 49 1.9k
H.-H. Parving Denmark 18 735 1.1× 769 1.5× 989 2.6× 231 0.6× 225 1.2× 30 2.1k
Christiane Rüster Germany 13 495 0.7× 244 0.5× 320 0.8× 313 0.9× 114 0.6× 21 1.3k

Countries citing papers authored by Sharon Anderson

Since Specialization
Citations

This map shows the geographic impact of Sharon Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Anderson more than expected).

Fields of papers citing papers by Sharon Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Anderson. The network helps show where Sharon Anderson may publish in the future.

Co-authorship network of co-authors of Sharon Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Anderson. A scholar is included among the top collaborators of Sharon Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Anderson. Sharon Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenberg, Mark E., Sharon Anderson, Samira Farouk, et al.. (2023). Reimagining Nephrology Fellowship Education to Meet the Future Needs of Nephrology. Clinical Journal of the American Society of Nephrology. 18(6). 816–825. 15 indexed citations
2.
Anderson, Sharon, Danny Orton, Sang Jun Han, et al.. (2019). Glomerular filtrate proteins in acute cardiorenal syndrome. JCI Insight. 4(4). 8 indexed citations
3.
Brown, Wendy Weinstock & Sharon Anderson. (2018). Women in Nephrology Leadership. Advances in Chronic Kidney Disease. 25(6). 519–522. 2 indexed citations
4.
Rao, Maya K., Cynthia D. Morris, Jean O’Malley, et al.. (2013). Documentation and Management of CKD in Rural Primary Care. Clinical Journal of the American Society of Nephrology. 8(5). 739–748. 8 indexed citations
5.
Hutchens, Michael P., Jennifer Dunlap, Wenri Zhang, et al.. (2010). Estrogen Is Renoprotective via  a Nonreceptor-dependent Mechanism after Cardiac Arrest In Vivo . Anesthesiology. 112(2). 395–405. 62 indexed citations
6.
Komers, Radko, et al.. (2010). Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Kidney International. 79(4). 432–442. 87 indexed citations
7.
Anderson, Sharon, Jeffrey B. Halter, William R. Hazzard, et al.. (2009). Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults. Journal of the American Society of Nephrology. 20(6). 1199–1209. 159 indexed citations
8.
Park, Jin Young, William E. Schutzer, Jessie N. Lindsley, et al.. (2007). p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels. BMC Nephrology. 8(1). 12–12. 52 indexed citations
9.
Komers, Radko, Jessie N. Lindsley, T Oyama, David Cohen, & Sharon Anderson. (2007). Renal p38 MAP kinase activity in experimental diabetes. Laboratory Investigation. 87(6). 548–558. 40 indexed citations
10.
Meyer, Mary M., et al.. (2004). Bone resorption and “relative” immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. American Journal of Kidney Diseases. 44(6). 1110–1114. 16 indexed citations
11.
Oyama, T, et al.. (1999). Hypertension and renal injury in experimental polycystic kidney disease. Kidney International. 56(6). 2181–2190. 35 indexed citations
12.
Piccirillo, Jay F., et al.. (1998). The inclusion of comorbidity in oncology data registries. Journal of Clinical Epidemiology. 51(2). 2 indexed citations
13.
Thomas, Susan E., Sharon Anderson, Katherine Gordon, et al.. (1998). Tubulointerstitial disease in aging. Journal of the American Society of Nephrology. 9(2). 231–242. 189 indexed citations
14.
Anderson, Sharon, et al.. (1997). Role of angiotensin II in diabetic nephropathy.. PubMed. 17(5). 441–7. 34 indexed citations
15.
Anderson, Sharon, et al.. (1994). Are Age-Related Differences in Response to Myocardial Ischemia and Cardioplegia pH Dependent?. Neonatology. 65(1). 25–35. 6 indexed citations
16.
Nahas, A. Meguid El, N P Mallick, & Sharon Anderson. (1993). Prevention of progressive chronic renal failure. Oxford University Press eBooks. 5 indexed citations
17.
Anderson, Sharon. (1992). Antihypertensive therapy in experimental diabetes.. Journal of the American Society of Nephrology. 3(4). S86–S86. 23 indexed citations
18.
Anderson, Sharon. (1990). Renal Effects of Converting Enzyme Inhibitors in Hypertension and Diabetes. Journal of Cardiovascular Pharmacology. 15. S11–15. 10 indexed citations
19.
Brater, D. Craig, Sharon Anderson, Norman M. Kaplan, & C. Venkata S. Ram. (1983). Effects of atenolol, nadolol and propranolol on renal haemodynamics. New Zealand medical journal. 96(743). 833–836. 2 indexed citations
20.
Anderson, Sharon & E. Holmgren. (1977). On acupuncture analgesia and the mechanism of pain. Pain. 4(Supp C). 93–94. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eberhard Ritz Breakdown of academic impact, for papers by A S Krolewski Breakdown of academic impact, for papers by Masahito Imanishi Breakdown of academic impact, for papers by Mari-Anne Gall Breakdown of academic impact, for papers by Gerjan Navis Breakdown of academic impact, for papers by Tatsuo Shiigai Breakdown of academic impact, for papers by Sandra Donnelly Breakdown of academic impact, for papers by Antonio Bossi Breakdown of academic impact, for papers by H.-H. Parving Breakdown of academic impact, for papers by Christiane Rüster
Rankless by CCL
2026